Sumitomo Life Insurance CO Biogen Inc. Transaction History

Sumitomo Life Insurance CO

  • $5.08 Billion
  • Q3 2024

A detailed history of Sumitomo Life Insurance CO transactions in Biogen Inc. stock. As of the latest transaction made, Sumitomo Life Insurance CO holds 3,906 shares of BIIB stock, worth $582,072. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,906
Previous 3,744 4.33%
Holding current value
$582,072
Previous $867,000 12.69%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$189.07 - $236.8 $30,629 - $38,361
162 Added 4.33%
3,906 $757,000
Q2 2024

Jul 19, 2024
SELL
$190.52 - $236.72 $87,829 - $109,127
-461 Reduced 10.96%
3,744 $867,000
Q1 2024

Apr 26, 2024
SELL
$212.02 - $267.71 $39,435 - $49,794
-186 Reduced 4.24%
4,205 $906,000
Q4 2023

Jan 30, 2024
SELL
$222.59 - $267.94 $50,750 - $61,090
-228 Reduced 4.94%
4,391 $1.14 Million
Q3 2023

Oct 23, 2023
SELL
$253.3 - $285.89 $15,451 - $17,439
-61 Reduced 1.3%
4,619 $1.19 Million
Q2 2023

Jul 20, 2023
SELL
$275.25 - $318.06 $120,559 - $139,310
-438 Reduced 8.56%
4,680 $1.33 Million
Q1 2023

Apr 27, 2023
SELL
$256.56 - $292.34 $13,341 - $15,201
-52 Reduced 1.01%
5,118 $1.42 Million
Q4 2022

Jan 17, 2023
SELL
$252.44 - $306.72 $70,178 - $85,268
-278 Reduced 5.1%
5,170 $1.43 Million
Q3 2022

Oct 31, 2022
SELL
$194.69 - $268.46 $77,486 - $106,847
-398 Reduced 6.81%
5,448 $1.46 Million
Q2 2022

Jul 22, 2022
BUY
$187.54 - $223.02 $36,007 - $42,819
192 Added 3.4%
5,846 $1.19 Million
Q1 2022

Apr 27, 2022
SELL
$193.77 - $244.14 $37,203 - $46,874
-192 Reduced 3.28%
5,654 $1.19 Million
Q4 2021

Feb 04, 2022
SELL
$223.92 - $287.77 $35,155 - $45,179
-157 Reduced 2.62%
5,846 $1.4 Million
Q3 2021

Oct 25, 2021
SELL
$282.99 - $369.05 $71,879 - $93,738
-254 Reduced 4.06%
6,003 $1.7 Million
Q2 2021

Jul 20, 2021
SELL
$259.0 - $414.71 $252,266 - $403,927
-974 Reduced 13.47%
6,257 $2.17 Million
Q1 2021

Apr 27, 2021
SELL
$242.95 - $284.63 $72,642 - $85,104
-299 Reduced 3.97%
7,231 $2.02 Million
Q4 2020

Feb 05, 2021
SELL
$236.26 - $355.63 $208,853 - $314,376
-884 Reduced 10.51%
7,530 $1.84 Million
Q3 2020

Oct 29, 2020
SELL
$264.77 - $305.71 $116,234 - $134,206
-439 Reduced 4.96%
8,414 $2.39 Million
Q2 2020

Jul 22, 2020
SELL
$258.66 - $342.55 $193,219 - $255,884
-747 Reduced 7.78%
8,853 $2.37 Million
Q1 2020

May 01, 2020
BUY
$268.85 - $341.04 $34,950 - $44,335
130 Added 1.37%
9,600 $3.04 Million
Q4 2019

Jan 24, 2020
BUY
$220.06 - $304.07 $117,291 - $162,069
533 Added 5.96%
9,470 $2.81 Million
Q3 2019

Oct 24, 2019
SELL
$217.44 - $243.88 $248,316 - $278,510
-1,142 Reduced 11.33%
8,937 $2.08 Million
Q2 2019

Jul 26, 2019
BUY
$219.29 - $241.72 $89,251 - $98,380
407 Added 4.21%
10,079 $2.36 Million
Q1 2019

Apr 17, 2019
SELL
$216.71 - $338.96 $242,931 - $379,974
-1,121 Reduced 10.39%
9,672 $2.29 Million
Q4 2018

Jan 24, 2019
BUY
$278.5 - $352.75 $78,815 - $99,828
283 Added 2.69%
10,793 $3.25 Million
Q3 2018

Oct 18, 2018
SELL
$293.51 - $383.83 $52,244 - $68,321
-178 Reduced 1.67%
10,510 $3.71 Million
Q2 2018

Jul 23, 2018
BUY
$257.52 - $306.91 $1.12 Million - $1.33 Million
4,340 Added 68.37%
10,688 $3.1 Million
Q1 2018

Apr 27, 2018
SELL
$260.13 - $367.91 $72,836 - $103,014
-280 Reduced 4.22%
6,348 $1.74 Million
Q4 2017

Feb 01, 2018
SELL
$307.64 - $344.58 $98,752 - $110,610
-321 Reduced 4.62%
6,628 $2.11 Million
Q3 2017

Oct 17, 2017
BUY
$281.15 - $329.69 $1.95 Million - $2.29 Million
6,949
6,949 $2.18 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sumitomo Life Insurance CO Portfolio

Follow Sumitomo Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email